Trending News Today: Pfizer Begins Trial for Duchenne Muscular Dystrophy Gene Therapy – Specialty Pharmacy Times
|
Trending News Today: Pfizer Begins Trial for Duchenne Muscular Dystrophy Gene Therapy
Specialty Pharmacy Times Pfizer has started a phase 1b trial for a Duchenne muscular dystrophy (DMD) gene therapy acquired as part of its $700 million takeover of Bamboo Therapeutics in 2016, FierceBiotech reported. The trial got underway when the first patient received a … |
